Wednesday, July 1, 2026 Live from SEC EDGAR

The Wire Search Saved

···

FilingIndex

AI-powered intelligence over every SEC filing. Search in plain English. Free.

Browse

Sectors
Themes
Search

Data

SEC EDGAR
About

Legal

Privacy
Disclaimer

© 2026 FilingIndex · Data sourced from SEC EDGAR (public domain).Not investment advice.

PDSB — PDS Biotechnology Corp SEC Filings | FilingIndex

PDSBNasdaq

PDS Biotechnology Corp

Pharmaceutical Preparations · DE · CIK 1472091

Developing targeted cancer and infectious disease immunotherapies using proprietary T cell activators

+ Watch View on EDGAR ↗

$59M

Market cap

$0.88

Last close

-2.0%

1D

-3.4%

5D

193K

Volume

Price · last 40 sessions-11.9%

May 4L $0.87 · H $1.43Jun 30

376

Total filings

Jun 26, 2026

Last filing

12/31

Fiscal year end

All 8-K · 266 10-Q · 32 DEFA14A · 12 DEF 14A · 12 10-K · 11 424B5 · 8 SC 13G · 7 425 · 7

SC 13GSC 13GJan 29, 2024 SC 13GSCHEDULE 13GJun 21, 2021 SC 13GSCHEDULE 13G (JEFFREY PEIERLS)Feb 21, 2020 SC 13GRE-FILING UNDER NEW JANUS HENDERSON GROUP PLC POST MERGERFeb 13, 2018 SC 13GSCHEDULE 13GApr 25, 2017

Similar companies

Comparable business profile · signals at a glance

ELTXElicio Therapeutics, Inc.$283.4M-2.3%CADLCandel Therapeutics, Inc.$627.2M-0.6%REPLReplimune Group, Inc.$733.2M-1.2%PGENPRECIGEN, INC.$1.6B-3.7%IOVAIOVANCE BIOTHERAPEUTICS, INC.

SC 13G

SC 13G

Feb 9, 2016

SC 13GSC 13GNov 10, 2015

$1.8B

-1.2%

ANIXAnixa Biosciences Inc$84.0M-1.8%